In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Gansu Duyiwei Biological Pharmaceutical Co. Ltd.

Latest From Gansu Duyiwei Biological Pharmaceutical Co. Ltd.

China’s Duyiwei Biological Acquires Two Hospitals, One More Soon

Gansu Duyiwei Biological Pharmaceutical Co. Ltd. plans to acquire Pengxi TCM Hospital, according to the company secretary, which follows two other purchases that include Deyang Better Future Hospital Co. Ltd. at RMB 25 million ($4 million) and Ziyang Jianshunwang Check-up Hospital Co. Ltd. for RMB 40 million.

China Deals

Deals Shaping The Medical Industry, April 2012

The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • China
  • Parent & Subsidiaries
  • Gansu Duyiwei Biological Pharmaceutical Co. Ltd.
  • Senior Management
  • Shuhu Tang, CFO
    Jin Zhu, Chmn.
  • Contact Info
  • Gansu Duyiwei Biological Pharmaceutical Co. Ltd.
    Phone: 28 85950888
    Jinjiang Industrial Dev. District
    # 456 Jinshi Rd
    Chengdu, 610063